Medical Marijuana Resources
- Medical Marijuana Law Presentation Maine Med Assn
- AAP Annual Leadership Forum - Passed Resolutions 2018
- Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research
- Difficulties conducting research of marijuana treatments (Schedule I category substance) to determine efficacy and safety, support towards research and development of pharmaceutical cannabinoids, suggestions to change to Schedule II substance
- Use of Medical Marijuana in Children in State Law
- Dangers of marijuana to the developing brain, issues that professionals with limited knowledge of chemical content or dosing are prescribing the liquid extract to infants, children and teens, challenges of no randomized clinical trials, recognition of both benefits and drawback of cannabinoids
- Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research